Vaccine manufacturer Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC on 26 January, Republic Day, the company’s CMD Krishna Ella announced.
The Central Drugs Standard Control Organization (CDSCO) had earlier this month given the go-ahead to Bharat Biotech for the first-of-its-kind nasal vaccine in India.
“Our nasal vaccine will be officially launched on Republic Day on 26 January,” Ella said at the India International Science Festival (IISF) held at the Maulana Azad National Institute of Technology (MANIT), media reports said.
The vaccine will be available at Rs 325 per shot for government procurement, and Rs 800 per shot for private vaccination centers.
The vaccine will be given as a booster shot for those above 18 years of age, irrespective of the primary vaccination dose. It will be administered to people twice, 28 days apart. The nasal vaccine can be taken after six months of the second dose.
According to the company, iNCOVACC is the world’s first intranasal vaccine for Covid-19 to have received approval for a primary two-dose schedule, and as a heterologous booster dose.
